HEALTHCARE | 2022 Q2 Report - Bryan, Garnier & Co
... PEPAXTI (Full Approval), argenx' VYVGART in. gMG (AChR+ pop.), Valneva's COVID vaccine, Formycon's biosimilar (assumedly the first Lucentis ...Télécharger HEALTHCARE | 2022 Q2 Report - Bryan, Garnier & Co pdf
